Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Inv. presentation
Appointed director
CC transcript
Neurotrope, Inc. (NTRP) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/29/2021 SC 13G/A INTRACOASTAL CAPITAL, LLC reports a 0% stake in Neurotrope, Inc.
12/07/2020 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur...
Docs: "SEPARATION AND DISTRIBUTION AGREEMENT",
"TAX MATTERS AGREEMENT",
"Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals"
12/03/2020 4 Gergel Ivan P. (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 7,813 options to buy @ $4.44, valued at $34.7k
Disposed/sold 10,000 options to buy @ $3.93, valued at $39.3k
Disposed/sold 10,000 options to buy @ $4.06, valued at $40.6k
Disposed/sold 10,000 options to buy @ $0.8203, valued at $8.2k
Disposed/sold 15,000 options to buy @ $0.972, valued at $14.6k
12/03/2020 4 Perry George (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 7,813 options to buy @ $7.55, valued at $59k
Disposed/sold 10,000 options to buy @ $8.9125, valued at $89.1k
Disposed/sold 10,000 options to buy @ $3.93, valued at $39.3k
Disposed/sold 10,000 options to buy @ $4.06, valued at $40.6k
Disposed/sold 10,000 options to buy @ $0.8203, valued at $8.2k
Disposed/sold 15,000 options to buy @ $0.972, valued at $14.6k
12/03/2020 4 Alkon Daniel L. (See Remarks) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 29,688 shares @ $0
Disposed/sold 5,469 options to buy @ $56, valued at $306.3k
Disposed/sold 124,274 options to buy @ $10.56, valued at $1.3M
Disposed/sold 167,000 options to buy @ $19.62, valued at $3.3M
Disposed/sold 150,000 options to buy @ $3.93, valued at $589.5k
Disposed/sold 40,000 options to buy @ $0.972, valued at $38.9k
12/03/2020 4 Ryan Charles S. (10% Owner) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 157,918 options to buy @ $7.55, valued at $1.2M
Disposed/sold 79,097 options to buy @ $4.37, valued at $345.7k
Disposed/sold 150,000 options to buy @ $3.93, valued at $589.5k
Disposed/sold 130,680 options to buy @ $0.7825, valued at $102.3k
Disposed/sold 40,000 options to buy @ $0.972, valued at $38.9k
12/03/2020 4 Bernstein Bruce (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 1,565 shares @ $0
Disposed/sold 7,813 options to buy @ $16.32, valued at $127.5k
Disposed/sold 15,535 options to buy @ $10.56, valued at $164k
Disposed/sold 10,000 options to buy @ $19.1, valued at $191k
Disposed/sold 10,000 options to buy @ $8.912, valued at $89.1k
Disposed/sold 25,000 options to buy @ $3.93, valued at $98.3k
Disposed/sold 10,000 options to buy @ $4.06, valued at $40.6k
Disposed/sold 10,000 options to buy @ $0.8203, valued at $8.2k
Disposed/sold 72,500 options to buy @ $0.972, valued at $70.5k
12/03/2020 4 Singer William S. (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 9,375 options to buy @ $32, valued at $300k
Disposed/sold 1,563 options to buy @ $35.52, valued at $55.5k
Disposed/sold 1,563 options to buy @ $71.04, valued at $111k
Disposed/sold 15,535 options to buy @ $10.56, valued at $164k
Disposed/sold 10,000 options to buy @ $19.1, valued at $191k
Disposed/sold 10,000 options to buy @ $8.9125, valued at $89.1k
Disposed/sold 25,000 options to buy @ $3.93, valued at $98.3k
Disposed/sold 10,000 options to buy @ $4.06, valued at $40.6k
Disposed/sold 10,000 options to buy @ $0.8203, valued at $8.2k
Disposed/sold 72,500 options to buy @ $0.972, valued at $70.5k
12/03/2020 4 WEINSTEIN ROBERT (See Remarks) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 3,953 shares @ $0
Disposed/sold 20,313 options to buy @ $32, valued at $650k
Disposed/sold 1,303 options to buy @ $25, valued at $32.6k
Disposed/sold 3,125 options to buy @ $25.6, valued at $80k
Disposed/sold 7,768 options to buy @ $10.56, valued at $82k
Disposed/sold 18,945 options to buy @ $19.62, valued at $371.7k
Disposed/sold 25,000 options to buy @ $3.93, valued at $98.3k
Disposed/sold 135,000 options to buy @ $0.972, valued at $131.2k
12/03/2020 4 Silverman Joshua (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 100,000 shares @ $0
Disposed/sold 9,375 options to buy @ $19.2, valued at $180k
Disposed/sold 124,275 options to buy @ $10.56, valued at $1.3M
Disposed/sold 10,000 options to buy @ $19.1, valued at $191k
Disposed/sold 167,000 options to buy @ $19.62, valued at $3.3M
Disposed/sold 10,000 options to buy @ $8.912, valued at $89.1k
Disposed/sold 150,000 options to buy @ $3.93, valued at $589.5k
Disposed/sold 10,000 options to buy @ $4.06, valued at $40.6k
Disposed/sold 10,000 options to buy @ $0.8203, valued at $8.2k
Disposed/sold 100,000 options to buy @ $0.972, valued at $97.2k
12/03/2020 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Disposed/sold 50,000 shares @ $0
Disposed/sold 7,813 options to buy @ $4.44, valued at $34.7k
Disposed/sold 1,562 options to buy @ $4.44, valued at $6.9k
Disposed/sold 10,000 options to buy @ $3.93, valued at $39.3k
Disposed/sold 10,000 options to buy @ $4.06, valued at $40.6k
Disposed/sold 10,000 options to buy @ $0.8203, valued at $8.2k
Disposed/sold 80,000 options to buy @ $0.972, valued at $77.8k
12/02/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/27/2020 4 Alkon Daniel L. (See Remarks) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 40,000 options to buy @ $0.972, valued at $38.9k
11/27/2020 4 Ryan Charles S. (10% Owner) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 40,000 options to buy @ $0.972, valued at $38.9k
11/27/2020 4 Bernstein Bruce (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 72,500 options to buy @ $0.972, valued at $70.5k
11/27/2020 4 Singer William S. (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 72,500 options to buy @ $0.972, valued at $70.5k
11/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/27/2020 4 Silverman Joshua (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Granted 100,000 options to buy @ $0.972, valued at $97.2k
11/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
11/24/2020 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/24/2020 8-K Other Events  Interactive Data
11/20/2020 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/20/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates"
11/09/2020 10-Q Quarterly Report for the period ended September 30, 2020
11/02/2020 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Bought 25,000 shares @ $0.9777, valued at $24.4k
10/26/2020 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Bought 25,000 shares @ $1.1, valued at $27.5k
10/22/2020 4 SCHECHTER JONATHAN (Director) has filed a Form 4 on Neurotrope, Inc.
Txns: Bought 2,012 shares @ $1.1, valued at $2.2k
Bought 22,988 shares @ $1.1, valued at $25.3k
10/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/30/2020 425 Form 425 - Prospectuses and communications, business combinations:
09/30/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy